GlobalData on MSN1mon
Medtronic shares dip after FDA tags insulin pump recall as Class IThe issue affects the MiniMed 600 series and 700 series pump systems – which supplies a flow of insulin to diabetes patients ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series in ...
class I recall of its MiniMed insulin pump system. This announcement comes during continued weak performance from Medtronic’s diabetes care division. The company identified a defect relating to ...
notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe ...
Patient safety is our priority, as is continuity of therapy, which is why we made the decision to voluntarily notify patients and will replace pumps when needed." About the Diabetes Business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback